![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears ConTIPI Medical’s Pelvic Prolapse Treatment
FDA Clears ConTIPI Medical’s Pelvic Prolapse Treatment
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
July 10, 2019
The FDA cleared ConTIPI Medical’s ProVate, a device used to temporarily manage pelvic organ prolapse in women without surgery.
The device consists of a vaginal ring pessary with a throwaway applicator. It can be removed by pulling a string, much like a tampon, and can be used for up to a week.
ProVate can be inserted and removed by the patient at home after initial training and size fitting by a medical practitioner.
Upcoming Events
-
21Oct